BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27935212)

  • 1. Hemophilia Liver Transplantation Observational Study.
    Ragni MV; Humar A; Stock PG; Blumberg EA; Eghtesad B; Fung JJ; Stosor V; Nissen N; Wong MT; Sherman KE; Stablein DM; Barin B
    Liver Transpl; 2017 Jun; 23(6):762-768. PubMed ID: 27935212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplant outcomes in HIV+ haemophilic men.
    Ragni MV; Devera ME; Roland ME; Wong M; Stosor V; Sherman KE; Hardy D; Blumberg E; Fung J; Barin B; Stablein D; Stock PG
    Haemophilia; 2013 Jan; 19(1):134-40. PubMed ID: 22762561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intention-to-treat survival analysis of hepatitis C virus/human immunodeficiency virus coinfected liver transplant: Is it the waiting list?
    Araiz JJ; Serrano MT; García-Gil FA; Lacruz EM; Lorente S; Sánchez JI; Suarez MA
    Liver Transpl; 2016 Sep; 22(9):1186-96. PubMed ID: 27114030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
    Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
    Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.
    Subramanian A; Sulkowski M; Barin B; Stablein D; Curry M; Nissen N; Dove L; Roland M; Florman S; Blumberg E; Stosor V; Jayaweera DT; Huprikar S; Fung J; Pruett T; Stock P; Ragni M
    Gastroenterology; 2010 Jan; 138(1):159-64. PubMed ID: 19800334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
    Terrault NA; Roland ME; Schiano T; Dove L; Wong MT; Poordad F; Ragni MV; Barin B; Simon D; Olthoff KM; Johnson L; Stosor V; Jayaweera D; Fung J; Sherman KE; Subramanian A; Millis JM; Slakey D; Berg CL; Carlson L; Ferrell L; Stablein DM; Odim J; Fox L; Stock PG;
    Liver Transpl; 2012 Jun; 18(6):716-26. PubMed ID: 22328294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
    Sawinski D; Goldberg DS; Blumberg E; Abt PL; Bloom RD; Forde KA
    Clin Infect Dis; 2015 Oct; 61(7):1054-62. PubMed ID: 26082506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease.
    Ragni MV; Eghtesad B; Schlesinger KW; Dvorchik I; Fung JJ
    Liver Transpl; 2005 Nov; 11(11):1425-30. PubMed ID: 16237709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diabetes and acute rejection on liver transplant outcomes: An analysis of the organ procurement and transplantation network/united network for organ sharing database.
    Kuo HT; Lum E; Martin P; Bunnapradist S
    Liver Transpl; 2016 Jun; 22(6):796-804. PubMed ID: 26850091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
    Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.
    Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR
    Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons.
    Balagopal A; Barin B; Quinn J; Rogers R; Sulkowski MS; Stock PG
    PLoS One; 2015; 10(8):e0135882. PubMed ID: 26313939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.
    Scherzer R; Heymsfield SB; Rimland D; Powderly WG; Tien PC; Bacchetti P; Shlipak MG; Grunfeld C;
    AIDS; 2017 Jan; 31(1):71-79. PubMed ID: 27677166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Duclos-Vallée JC; Féray C; Sebagh M; Teicher E; Roque-Afonso AM; Roche B; Azoulay D; Adam R; Bismuth H; Castaing D; Vittecoq D; Samuel D;
    Hepatology; 2008 Feb; 47(2):407-17. PubMed ID: 18098295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection.
    Tencer T; Friedman HS; Li-McLeod J; Johnson K
    J Manag Care Pharm; 2007; 13(9):790-8. PubMed ID: 18062730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
    Watt KD; Lyden ER; Gulizia JM; McCashland TM
    Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus coinfection with special reference to hemophiliac recipients in Japan.
    Eguchi S; Soyama A; Hidaka M; Takatsuki M; Muraoka I; Tomonaga T; Kanematsu T
    Surg Today; 2011 Oct; 41(10):1325-31. PubMed ID: 21922353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
    Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V
    Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.